Clinical Trial Update: CCT-102 or Expectant Management in Delayed Pregnancy Loss [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating CCT-102 versus expectant management for early or delayed pregnancy loss has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Miscarriage

Drugs mentioned

• CCT-102

Snippet

Sponsor: Conceptra Biosciences, LLC | Conditions: Early Pregnancy Loss, Delayed Pregnancy Loss | Phase 3 | Status: COMPLETED